Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct-Dec;30(4):310-317.
doi: 10.1097/WAD.0000000000000153.

GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil

Affiliations

GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil

Leonel T Takada et al. Alzheimer Dis Assoc Disord. 2016 Oct-Dec.

Abstract

Background: Mutations in GRN (progranulin) and MAPT (microtubule-associated protein tau) are among the most frequent causes of monogenic frontotemporal dementia (FTD), but data on the frequency of these mutations in regions such as Latin America are still lacking.

Objective: We aimed to investigate the frequencies of GRN and MAPT mutations in FTD cohorts from 2 Brazilian dementia research centers, the University of Sao Paulo and the Federal University of Minas Gerais medical schools.

Methods: We included 76 probands diagnosed with behavioral-variant FTD (n=55), semantic-variant Primary Progressive Aphasia (PPA) (n=11), or nonfluent-variant PPA (n=10). Twenty-five percent of the cohort had at least 1 relative affected with FTD.

Results: Mutations in GRN were identified in 7 probands, and in MAPT, in 2 probands. We identified 3 novel GRN mutations (p.Q130X, p.317Afs*12, and p.K259Afs*23) in patients diagnosed with nonfluent-variant PPA or behavioral-variant FTD. Plasma progranulin levels were measured and a cutoff value of 70 ng/mL was found, with 100% sensitivity and specificity to detect null GRN mutations.

Conclusions: The frequency of GRN mutations was 9.6% and that of MAPT mutations was 7.1%. Among familial cases of FTD, the frequency of GRN mutations was 31.5% and that of MAPT mutations was 10.5%.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Neuroimaging of probands Brain MRI scans (A) Proband USP 58’s sister. Axial FLAIR images. White matter hyperintensities appear as atrophy in frontal, temporal and parietal regions progress. (B) Axial FLAIR images from proband USP 64 show global cortical atrophy with periventricular white matter hyperintensities. (C) Axial FLAIR images from Proband UFMG 18 show left anteromedial temporal lobe atrophy and subtle white matter hyperintensities.
Figure 2
Figure 2
Neuropathological findings in proband USP 63 Macroscopy (A-D): global cortical atrophy, predominantly in the frontal, temporal and parietal lobes. Atrophy is slightly more significant on the right hemisphere. Views: dorsal (A); ventral (B); lateral of right hemisphere (C); lateral of left hemisphere (D). Microscopy (E-F, 400x): Immunohistochemistry with antibodies against hyperphosphorylated TDP-43 showing neuronal cytoplasmic inclusions (red arrow) in the granule cell layer of the dentate gryus (E) and short dystrophic neurites (red arrow) in the entorhinal cortex (F).
Figure 3
Figure 3
Dot plot of plasma progranulin levels. FTD: frontotemporal dementia; GRN+: with null GRN mutations; GRN−: without null GRN mutations. Values shown as mean ± standard deviation (range) in ng/ml. Red dotted lines indicate the means.

References

    1. Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73(18):1451–1456. - PMC - PubMed
    1. Goldman JS, Farmer JM, Wood EM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65(11):1817–1819. - PubMed
    1. Le Ber I, Camuzat A, Guillot-Noel L, et al. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis. 2013;34(2):485–499. - PubMed
    1. Ghidoni R, Stoppani E, Rossi G, et al. Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study. Neurodegener Dis. 2012;9(3):121–127. - PubMed
    1. Finch N, Baker M, Crook R, et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain. 2009;132(Pt 3):583–591. - PMC - PubMed